C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
01/2012
01/03/2012	CA2347025C Zinc finger binding domains for gnn
01/03/2012	CA2304952C Mannose-receptor bearing cells and antigen conjugate for immunotherapy
01/03/2012	CA2282719C A method for producing procollagen
01/03/2012	CA2261346C Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases
01/03/2012	CA2260855C Polynucleotide vaccine formula in particular against bovine respiratory pathology
01/03/2012	CA2258348C Screening compounds for the ability to alter the production of amyloid-.beta. peptide (x-.gtoreq.41)
01/03/2012	CA2227265C Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
01/03/2012	CA2226973C Modulators of the function of fas receptors and other proteins
01/03/2012	CA2224468C P53 protein variants and therapeutical uses thereof
01/03/2012	CA2221092C Genetic control of flowering
01/03/2012	CA2215483C Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same
01/03/2012	CA2178482C Thrombopoietin
12/2011
12/29/2011	WO2011163628A2 Dengue virus (dv) polypeptide sequences, t cell epitopes and methods and uses thereof
12/29/2011	WO2011163558A1 Materials and methods for assay of anti-hepatitis c virus (hcv) antibodies
12/29/2011	WO2011163531A2 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases
12/29/2011	WO2011163473A1 Glucagon analogs exhibiting enhanced solubility and stability in physiological ph buffers
12/29/2011	WO2011163460A1 Yl-based insulin-like growth factors exhibiting high activity at the insulin receptor
12/29/2011	WO2011163398A2 Biomimetic peptides for bone augmentation
12/29/2011	WO2011163269A1 Aspergillus aculeatus derived polypeptides having c4-dicarboxylic acid transporter activity and polynucleotides encoding same
12/29/2011	WO2011162968A1 Dipeptide linked medicinal agents
12/29/2011	WO2011162805A2 Prion inactivation using ozone
12/29/2011	WO2011162655A1 Compound and method for treatment of alzheimer's disease and familial dementia
12/29/2011	WO2011162627A1 A method of producing bacteriophages
12/29/2011	WO2011161970A1 Anti-pdgf receptor antibody
12/29/2011	WO2011161466A1 Plant eukaryotic translation initiation factor 4e
12/29/2011	WO2011161431A2 Methyltransferase nucleic acids and polypeptides
12/29/2011	WO2011161332A1 Novel octapeptide compounds and therapeutic use thereof
12/29/2011	WO2011161260A1 Anticancer fusion protein
12/29/2011	WO2011161244A1 Homodimeric protein constructs
12/29/2011	WO2011161125A1 Insulin derivatives containing additional disulfide bonds
12/29/2011	WO2011161124A1 Insulin analogues containing additional disulfide bonds
12/29/2011	WO2011161083A1 Human insulin containing additional disulfide bonds
12/29/2011	WO2011161063A1 Leaa from trichoderma reesei
12/29/2011	WO2011161017A1 New medium, devices and methods
12/29/2011	WO2011161007A1 Reversed phase hplc purification of a glp-1 analogue
12/29/2011	WO2011160848A1 Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
12/29/2011	WO2011160827A2 Novel jnk inhibitor molecules
12/29/2011	WO2011160664A1 Treatment of vascular complications of diabetes
12/29/2011	WO2011160653A1 Novel jnk inhibitor molecules
12/29/2011	WO2011160633A1 Glucagon analogues
12/29/2011	WO2011160630A2 Glucagon analogues
12/29/2011	WO2011160563A1 Novel porcine interferon and use thereof
12/29/2011	WO2011160264A1 Cationized carrier protein and conjugate of said carrier protein and zearalenone
12/29/2011	WO2011160237A1 Genetic markers associated with intellectual disability
12/29/2011	WO2011160189A1 METHOD OF SCREENING FOR INHIBITORS OF sPLA2-IIA
12/29/2011	WO2011140086A9 Serum albumin binding molecules
12/29/2011	WO2011138671A3 Tubby-like protein isoforms and their applications
12/29/2011	WO2011131510A3 Selective modification of proteins
12/29/2011	WO2011121576A3 Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
12/29/2011	WO2011112671A3 Conversion of vascular endothelial cells into multipotent stem-like cells
12/29/2011	WO2011100468A3 Methods and materials for treating cancer
12/29/2011	WO2011091350A3 Methods & compositions for improving protein production
12/29/2011	WO2011090973A3 Immunotherapy compositions and methods of treatment
12/29/2011	WO2011056975A4 Genetically encoded calcium indicators and methods of use
12/29/2011	WO2002042415A9 Agents for blocking t cell mediated immune reactions
12/29/2011	WO2002031116A9 Gene expression modulated in spontaneous inflammatory bowel disease
12/29/2011	WO2001053458A9 Methods and reagents for performing antimicrobial compound screening
12/29/2011	US20110321201 CaWRKYd, A HOT PEPPER TRANSCRIPTION FACTOR GENE INVOLVED IN PLANT DEFENSE AND TRANSGENIC PLANTS USING THE SAME
12/29/2011	US20110321198 Polypeptide having function for delaying anthesis or suppressing growth, polynucleotide encoding the same, and use thereof
12/29/2011	US20110321189 Polynucleotides and polypeptides involved in post-transcriptional gene silencing
12/29/2011	US20110321183 Methods for ligation and uses thereof
12/29/2011	US20110319869 Human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
12/29/2011	US20110319603 Method for fluorescently labeling protein
12/29/2011	US20110319602 T2r taste receptors and genes encoding same
12/29/2011	US20110319601 Inorganic Particle Conjugates
12/29/2011	US20110319599 MN Gene and Protein
12/29/2011	US20110319595 Flagellin related polypeptides and uses thereof
12/29/2011	US20110319593 Process for the production of biologically active hiv-1 tat protein
12/29/2011	US20110319591 Pegylated, extended insulins
12/29/2011	US20110319590 Tumour Cell Lines and Uses Thereof
12/29/2011	US20110319493 Histone deacetylases, and uses related thereto
12/29/2011	US20110319480 Method of Inducing and/or Enhancing an Immune Response to Tumor Antigens
12/29/2011	US20110319339 Neurotensin-derived branched peptides and uses thereof
12/29/2011	US20110319338 Peptides that bind eukaryotic translation initiation factor 4e
12/29/2011	US20110319337 Dominant Negative WNT2 Compositions and Methods of Use
12/29/2011	US20110319336 Selective anticancer chimeric peptide
12/29/2011	US20110319327 Polypeptides Homologous to VEGF and BMP1
12/29/2011	US20110319319 Antimicrobial kinocidin compositions and methods of use
12/29/2011	US20110319293 Synthetic protease substrates, assay methods using such substrates and kits for practicing the assay
12/29/2011	US20110318834 Multiple-tumor aberrant growth genes
12/29/2011	US20110318832 Human Telomerase Catalytic Subunit
12/29/2011	US20110318830 Compositions and methods for re-programming and re-differentiating cells
12/29/2011	US20110318809 Method of screening placental proteins responsible for pathophysiology of preeclampsia, and marker for early diagnosis and prediction of preeclampsia
12/29/2011	US20110318806 Site specific incorporation of keto amino acids into proteins
12/29/2011	US20110318788 Multisignal labeling reagents and processes and uses therefor
12/29/2011	US20110318787 Means and methods for modulating notch3 protein expression and/or the coding region of notch3; compositions and use thereof in the treatment of cadasil
12/29/2011	US20110318765 Method for pre-treating sample containing glycated hemoglobin
12/29/2011	US20110318408 Hla class i a2 tumor associated antigen peptides and vaccine compositions
12/29/2011	US20110318400 Skin Care Product
12/29/2011	US20110318385 Engineered botulinum neurotoxin c1 with selective substrate specificity
12/29/2011	US20110318380 MHC Multimers in Cancer Vaccines and Immune Monitoring
12/29/2011	US20110318377 Methylated TAT Polypeptides and Methods of Use Thereof
12/29/2011	US20110318376 Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins
12/29/2011	US20110318373 Immunosuppression modulating compounds
12/29/2011	US20110318372 Indoleamine 2,3-dioxygenase based immunotherapy
12/29/2011	US20110318371 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
12/29/2011	US20110318363 Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
12/29/2011	US20110318362 Novel card proteins involved in cell death regulation
12/29/2011	US20110318355 Mutant proteins of the f protein of piv-5 and piv-2
12/29/2011	US20110318354 Cytokine receptor zcytor17 multimers

1 ... 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 ... 2916